Literature DB >> 26699632

The History of Primary Angioplasty and Stenting for Acute Myocardial Infarction.

Nathaniel R Smilowitz1, Frederick Feit2.   

Abstract

The evolution of the management of acute myocardial infarction (MI) has been one of the crowning achievements of modern medicine. At the turn of the twentieth century, MI was an often-fatal condition. Prolonged bed rest served as the principal treatment modality. Over the past century, insights into the pathophysiology of MI revolutionized approaches to management, with the sequential use of surgical coronary artery revascularization, thrombolytic therapy, and percutaneous coronary intervention (PCI) with primary coronary angioplasty, and placement of intracoronary stents. The benefits of prompt revascularization inspired systems of care to provide rapid access to PCI. This review provides a historical context for our current approach to primary PCI for acute MI.

Entities:  

Keywords:  Angioplasty; Coronary artery disease; History; Myocardial infarction; Percutaneous coronary intervention; Stent; Thrombolysis

Mesh:

Year:  2016        PMID: 26699632     DOI: 10.1007/s11886-015-0681-x

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  85 in total

1.  The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy.

Authors:  A P FLETCHER; N ALKJAERSIG; F E SMYRNIOTIS; S SHERRY
Journal:  Trans Assoc Am Physicians       Date:  1958

2.  Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.

Authors:  Sanjit S Jolly; Salim Yusuf; John Cairns; Kari Niemelä; Denis Xavier; Petr Widimsky; Andrzej Budaj; Matti Niemelä; Vicent Valentin; Basil S Lewis; Alvaro Avezum; Philippe Gabriel Steg; Sunil V Rao; Peggy Gao; Rizwan Afzal; Campbell D Joyner; Susan Chrolavicius; Shamir R Mehta
Journal:  Lancet       Date:  2011-04-04       Impact factor: 79.321

Review 3.  Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models.

Authors:  K A Reimer; R S Vander Heide; V J Richard
Journal:  Am J Cardiol       Date:  1993-12-16       Impact factor: 2.778

Review 4.  Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

Authors:  Richard E Waters; Kanwar P Singh; Matthew T Roe; Mat Lotfi; Michael H Sketch; Kenneth W Mahaffey; L Kristin Newby; John H Alexander; Robert A Harrington; Robert M Califf; Christopher B Granger
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

5.  Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.

Authors:  R J Gibbons; D R Holmes; G S Reeder; K R Bailey; M R Hopfenspirger; B J Gersh
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

6.  Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study.

Authors:  R A Schatz; D S Baim; M Leon; S G Ellis; S Goldberg; J W Hirshfeld; M W Cleman; H S Cabin; C Walker; J Stagg
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

Review 7.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

8.  A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.

Authors:  E J Topol; R M Califf; B S George; D J Kereiakes; C W Abbottsmith; R J Candela; K L Lee; B Pitt; R S Stack; W W O'Neill
Journal:  N Engl J Med       Date:  1987-09-03       Impact factor: 91.245

9.  Treatment of myocardial infarction with intracoronary streptokinase: efficacy and safety data from 209 United States cases in the Hoechst-Roussel registry.

Authors:  J Weinstein
Journal:  Am Heart J       Date:  1982-10       Impact factor: 4.749

10.  Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

Authors:  Sripal Bangalore; Sunil Kumar; Mario Fusaro; Nicholas Amoroso; Michael J Attubato; Frederick Feit; Deepak L Bhatt; James Slater
Journal:  Circulation       Date:  2012-05-14       Impact factor: 29.690

View more
  4 in total

Review 1.  New Therapeutic Options for Type 2 Diabetes Mellitus and Their Impact Against Ischemic Heart Disease.

Authors:  Malak Almutairi; Jordan S F Chan; John R Ussher
Journal:  Front Physiol       Date:  2022-06-27       Impact factor: 4.755

Review 2.  Endothelial Dysfunction and Coronary Vasoreactivity - A Review of the History, Physiology, Diagnostic Techniques, and Clinical Relevance.

Authors:  Tharusha Gunawardena; Ioannis Merinopoulos; Upul Wickramarachchi; Vassilios Vassiliou; Simon Eccleshall
Journal:  Curr Cardiol Rev       Date:  2021

Review 3.  Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at risk.

Authors:  Thomas J Cahill; Rajesh K Kharbanda
Journal:  World J Cardiol       Date:  2017-05-26

4.  Network-Assisted Systems Biology Analysis of the Mitochondrial Proteome in a Pre-Clinical Model of Ischemia, Revascularization and Post-Conditioning.

Authors:  Alex Gallinat; Gemma Vilahur; Teresa Padró; Lina Badimon
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.